Login

Journal Front Page

News & Events

  • April 2024 Issue delayed
  • Dear Researcher, It Pleased to inform you that, Asian Journal of Pharmaceutical Education and Research, Volume 13, Issue 2 (April 2024) Issue) schedule published on 15 April 2024 is delay due to some technical problem. It will published on 22 April 2024. Sorry for inconvenience. For other details You can vist the website http://www.ajper.com
  • Call for article for April 2024 issue
  • Submissions of Review, Research Article, Short Communication and Case study are being accepted for the current and future issues before 15 March, 2024 of this journal by online process or editor@ajper.com, or ajper.editor@gmail.com. Further information can be found at www.ajper.com.
  • January 2024 Issue published
  • Dear Researcher, It Pleased to inform you that, Asian Journal of Pharmaceutical Education and Research, has successfully launch Volume 13, Issue 1 (January 2024) Issue). You can find the article on http://ajper.com/current_issue.php Article also invited for the Next coming Issue from your side. For More details Visit: www.ajper.com
  • Application For Reviewer
  • We are now going to reconstitute our editorial board members of Reviewer. Please send your resume at ajper.editor@gmail.com and be a part of the editorial board member as Reviewer.
  • AJPER Impact facor
  • It is to pleasure that Ajper SJIF imact facor has increse from 5.019 to 7.014. Also global impact factor incresed from 0.654 to 0.765.
  • ICV
  • AJPER Rank with Index Copernicus Value 61.10 due to high reputation at International Level

Abstract

FORMULATION AND EVALUATION OF LIPOSOMAL GEL FOR EFFECTIVE TREATMENT OF ACNE

Singh Nishantkumar Ramkrishna1*, Hemant Kumar Dharma1, Neelesh Choubey1, C.K. Tyagi1, Prabhakar Budholiya1, Geeta parkhe2

1 College of Pharmacy, Sri Satya Sai University of Technology and Medical Sciences, Sehore (M. P.).
2 Scan Research Laboratories, Bhopal (M.P.)

ABSTRACT

Approximately 95% of the population suffers at some point in their lifetime from acne vulgaris. Acne is a multifactorial disease of the pilosebaceous unit. This inflammatory skin disorder is most common in adolescents but also affects neonates, prepubescent children and adults. Topical conventional systems are associated with various side effects. Novel drug delivery systems have been used to reduce the side effect of drugs commonly used in the topical treatment of acne. Topical treatment of acne with active pharmaceutical ingredients (API) makes direct contact with the target site before entering the systemic circulation which reduces the systemic side effect of the parenteral or oral administration of drug. Liposomal formulations have been successfully used in the treatment of a number of dermatological diseases. Various synthetic as well as herbal drugs are incorporated into liposome to improve its efficacy. Clindamycin phosphate is an antibiotic useful for the treatment of a number of infections. It is of the lincosamide class. Clindamycin phosphate is a semi synthetic lincosamide antibiotic that has largely replaced lincomycin due to an improved side effect profile. Clindamycin inhibits bacterial protein synthesis by binding to bacterial 50S ribosomal subunits. Topical Clindamycin phosphate reduces free fatty acid concentrations on the skin and suppresses the growth of Propionibacterium acnes (Corynebacterium acnes), an anaerobe found in sebaceous glands and follicles. Clindamycin loaded liposomes were prepared and characterized for vesicle size, surface charge and vesicle size, entrapment efficiency, pH measurements and stability. Clindamycin liposomal gels were formulated and evaluated comparatively with commercial gel with respect to measurement of viscosity, drug content, extrudability study, spreadability, in vitro drug diffusion study and stability studies. All the prepared liposomal gel showed acceptable physical properties, homogeneity, consistency, spreadability, viscosity and pH value. The best formulation F8 showed better anti-acne activity when compared with all formulation.

Keywords: Acne vulgaris, Clindamycin phosphate, Topical treatment, Liposomal.


[Full Text Article]